MR-Guided Cryoablation of Prostate Bed Recurrences

StatusEnrolling by Invitation
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Nov 2026 → Dec 2028
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Mayo Clinic

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Nov 2026 to Dec 2028 Show 4 more changesShow less
    • Primary endpoint(s) modified
    • Trial status changed: Active, Not Recruiting → Enrolling by Invitation
    • Enrollment increased: 107 → 200 participants
    • Eligibility criteria expanded, about 12 words
  2. Re-verified, no change to tracked fieldsv21
  3. Primary and study completion dates: Oct 2024 to Nov 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 200 to confirmed 107
    • Site details revised
    v20
  4. Re-verified, no change to tracked fieldsv19
  5. Enrollment target: 100 to 200
    • Primary and study completion dates: Jul 2024 to Oct 2024
    • Eligibility criteria shortened, about 13 words
    v18
Show 16 earlier versionsHide 16 earlier versions
  1. Primary and study completion dates: Jul 2023 to Jul 2024v17
  2. Primary completion date: Dec 2022 to Jul 2023
    • Study completion date: Dec 2023 to Jul 2023
    v16
  3. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v15
  4. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v14
  5. Re-verified, no change to tracked fieldsv13
  6. Site contact updatedv12
  7. Primary completion date: Jan 2019 to Dec 2022
    • Study completion date: Jan 2022 to Dec 2023
    • Start date: Nov 2012 to Dec 12, 2012
    v11
  8. 2 versions Re-verified since Apr 4, 2017, no change to tracked fieldsv9-v10
  9. Primary completion date: Jan 2016 to Jan 2019
    • Study completion date: Jan 2019 to Jan 2022
    v8
  10. 3 versions Re-verified since Feb 3, 2015, no change to tracked fieldsv5-v7
  11. Primary endpoint revised
    • Study completion date: Jan 2016 to Jan 2019
    v4
  12. Re-verified, no change to tracked fieldsv3
  13. Primary completion date: Jan 2015 to Jan 2016
    • Primary endpoints: 3 to 1
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Mayo Clinic
1,027 trials monitored
See 130 trials at risk
Prostate Cancer
2,562 trials monitored
See 170 trials at risk
The purpose of this research is to see if MR-guided cryoablation can effectively treat prostate tumor recurrences.
Trial Details
NCT Number NCT01727284
Lead Sponsor Mayo Clinic
Conditions
(from sponsor)		 Prostate Tumors
Related terms Prostatic Neoplasms
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov